Shibasaki Yasushi, Sakaguchi Takanori, Hiraide Takanori, Morita Yoshifumi, Suzuki Atsushi, Baba Satoshi, Setou Mitsutoshi, Konno Hiroyuki
Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
J Surg Res. 2015 Feb;193(2):567-76. doi: 10.1016/j.jss.2014.07.055. Epub 2014 Jul 31.
Indocyanine green (ICG), an organic anion used in liver function tests, is known to accumulate in hepatocellular carcinoma (HCC) tissues after an intravenous injection. Because the intratumoral expression of transporters for chemical agents influences the behaviors of some malignant tumors, we investigated whether the expression of ICG-related transporters influenced the clinicopathologic features of HCC.
ICG accumulation patterns were examined using near-infrared spectroscopy and the protein expression of ICG-related transporters was assessed using immunohistochemistry and immunoblotting in 40 resected HCC specimens. We also determined whether the intratumor expression of these transporters affected intratumor lipid composition by imaging mass spectrometry.
Immunoblot analysis revealed that the expression of organic anion transporting polypeptide 1B3 (OATP1B3) and multidrug resistance p-glycoprotein (MDR)-3, as influx and efflux transporters, respectively, were significantly higher in ICG-accumulated HCC (ICG-high HCC) than in ICG-low HCC. ICG was fluorescently observed in the pseudoglands and bile canaliculi abundantly expressing MDR3. An immunohistochemical examination revealed significantly worse disease-free and overall survival rates in patients with MDR3-negative HCC, in which the intratumoral accumulation of some phosphatidylcholine species was observed under imaging mass spectrometry.
The intratumoral expression of MDR3, a key efflux transporter of ICG, affected the prognosis of patients with HCC, presumably by altering the lipid composition of the lipid bilayers.
吲哚菁绿(ICG)是一种用于肝功能测试的有机阴离子,已知静脉注射后会在肝细胞癌(HCC)组织中蓄积。由于化学物质转运蛋白的肿瘤内表达会影响某些恶性肿瘤的行为,我们研究了ICG相关转运蛋白的表达是否会影响HCC的临床病理特征。
使用近红外光谱检查ICG蓄积模式,并采用免疫组织化学和免疫印迹法评估40例切除的HCC标本中ICG相关转运蛋白的蛋白表达。我们还通过成像质谱法确定这些转运蛋白的肿瘤内表达是否会影响肿瘤内脂质组成。
免疫印迹分析显示,作为流入和流出转运蛋白,有机阴离子转运多肽1B3(OATP1B3)和多药耐药P-糖蛋白(MDR)-3在ICG蓄积的HCC(ICG高表达HCC)中的表达明显高于ICG低表达HCC。在大量表达MDR3的假腺泡和胆小管中荧光观察到ICG。免疫组织化学检查显示,MDR3阴性HCC患者的无病生存率和总生存率明显较差,在成像质谱下观察到这些患者肿瘤内某些磷脂酰胆碱种类的蓄积。
ICG的关键流出转运蛋白MDR3的肿瘤内表达可能通过改变脂质双层的脂质组成影响HCC患者的预后。